• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon

MPS 2024

June 10 - 14, Seattle, USA

Microphysiological systems (MPS) comprise a number of bioengineering breakthroughs that reproduce organ architecture and function in vitro. Fueled by stem-cell technologies, a broad variety of especially human models and test systems have emerged, which make relevant experimental tools broadly available through international and multidisciplinary collaborations.

40+ international organizations and companies have teamed up for a series of annual MPS World Summits to present the latest scientific achievements, discuss the advances and challenges, and enable communication between young and newly interested scientists and pioneers of the MPS field.

Meet us at booth #39 and check out our posters:

Posters & Talks

  • Workshop "Using MPS for high-throughput phenotypic screening"
    Monday, June 10 2024, 1 PM - 4:30 PM
  • Workshop "Educational Workshop-Career in Industry"
    Monday, June 10 2024, 2:10 PM - 3:20 PM
  • Presentation #531 "A Novel Microfluidic Device for Modeling an Artery-on-a-Chip and Cardiovascular Diseases Uniflow presentation"
    Tuesday, June 11 2024, 12:40 PM - 1 PM
  • Poster #131 "Patient derived HCC-on-Chip models recapitulate Sorafenib and Lenvatinib induced vascular responses"
    Thursday, June 13 2024, 10 AM - 11:30 AM
  • Poster #432 "Modeling chemotherapy-induced peripheral neuropathy on-a-chip"
    Thursday, June 13 2024, 10 AM - 11:30 AM
  • Presentation #669 "Partnering with pharma: How MPS supports the next wave of immune oncology programs"
    Thursday, June 13 2024, 2:30 PM - 2:50 PM
  • Poster #315 "A high-throughput kidney-on-a-chip platform for chronic kidney disease therapy discovery"
    Thursday, June 13 2024, 3:40 PM - 4 PM
  • Poster #280 "An automated and multiplexed liver fibrosis screening assay on a microfluidic liver model that recapitulates the cellular composition and organization of the hepatic lobule"
    Thursday, June 13 2024, 3:40 PM - 4 PM


Schedule a meeting with us


Link to the conference homepage


May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all